Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Medpace Holdings, Inc. MEDP
$209.47
-$0.04 (-0.02%)
На 18:00, 12 мая 2023
Ранг: 1
Ключевые показатели
-
Marketcap
6410453334.00000000
-
week52high
241.48
-
week52low
128.99
-
Revenue
1459996000
-
P/E TTM
25
-
Beta
1.42283700
-
EPS
8.08000000
-
Last Dividend
0.00000000
-
Next Earnings Date
24 июл 2023 г. в 10:59
Описание компании
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Guggenheim | Neutral | 24 мая 2022 г. | |
| Credit Suisse | Outperform | Outperform | 20 июл 2021 г. |
| Credit Suisse | Outperform | Outperform | 17 мар 2021 г. |
| Truist Securities | Buy | Buy | 17 февр 2021 г. |
| Credit Suisse | Outperform | Outperform | 16 февр 2021 г. |
| UBS | Sell | 07 сент 2022 г. | |
| UBS | Neutral | Sell | 27 окт 2022 г. |
| Baird | Neutral | Neutral | 26 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Gwadry-Sridhar Femida H. | A | 573 | 573 | 16 янв 2023 г. |
| Carley Brian T | A | 413 | 413 | 09 дек 2022 г. |
| McCarthy Cornelius P. III | A | 328 | 328 | 09 дек 2022 г. |
| Kraft Robert O. | A | 376 | 376 | 09 дек 2022 г. |
| Brady Kevin M. | D | 3000 | 344 | 16 ноя 2022 г. |
| GEIGER JESSE J | D | 0 | 7000 | 15 ноя 2022 г. |
| GEIGER JESSE J | D | 6382 | 7000 | 15 ноя 2022 г. |
| GEIGER JESSE J | A | 13382 | 7000 | 15 ноя 2022 г. |
| Brady Kevin M. | D | 3344 | 1656 | 15 ноя 2022 г. |
| Kraft Robert O. | D | 0 | 9630 | 01 ноя 2022 г. |
Новостная лента
Medpace: Gaining Market Share While Others Struggle
Seeking Alpha
08 мая 2023 г. в 14:22
Medpace is one the largest Clinical Research Organisations in the market, and consistently winning market share. On April 24, Medpace presented its earnings for the first quarter of FY23, showing operative strength in a challenging market environment.
Medpace Holdings Crushed Analyst Expectations
The Motley Fool
06 мая 2023 г. в 08:00
We've got a look at this company, what's going on with Pepsi, and other market news.
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
Zacks Investment Research
03 мая 2023 г. в 14:27
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
New Strong Buy Stocks for May 3rd
Zacks Investment Research
03 мая 2023 г. в 09:07
COCO, RYI, GTX, MEDP and SKX have been added to the Zacks Rank #1 (Strong Buy) List on May 3rd, 2023.
Why MTY Food Group Is Worth a Look
The Motley Fool
29 апр 2023 г. в 07:00
You might be familiar with some of the brands, but the company's name is probably not on your radar.